Literature DB >> 23726512

Subanesthetic dose ketamine does not induce an affective switch in three independent samples of treatment-resistant major depression.

Mark J Niciu1, David A Luckenbaugh, Dawn F Ionescu, Daniel C Mathews, Erica M Richards, Carlos A Zarate.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23726512      PMCID： PMC3805682          DOI： 10.1016/j.biopsych.2013.01.038

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  12 in total

1.  A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.

Authors:  Nancy Diazgranados; Lobna Ibrahim; Nancy E Brutsche; Andrew Newberg; Phillip Kronstein; Sami Khalife; William A Kammerer; Zenaide Quezado; David A Luckenbaugh; Giacomo Salvadore; Rodrigo Machado-Vieira; Husseini K Manji; Carlos A Zarate
Journal:  Arch Gen Psychiatry       Date:  2010-08

2.  A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

Authors:  Carlos A Zarate; Jaskaran B Singh; Paul J Carlson; Nancy E Brutsche; Rezvan Ameli; David A Luckenbaugh; Dennis S Charney; Husseini K Manji
Journal:  Arch Gen Psychiatry       Date:  2006-08

3.  A rating scale for mania: reliability, validity and sensitivity.

Authors:  R C Young; J T Biggs; V E Ziegler; D A Meyer
Journal:  Br J Psychiatry       Date:  1978-11       Impact factor: 9.319

4.  Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression.

Authors:  Paul E Keck; Sara A Corya; Lori L Altshuler; Terence A Ketter; Susan L McElroy; Michael Case; Susan D Briggs; Mauricio Tohen
Journal:  J Clin Psychiatry       Date:  2005-05       Impact factor: 4.384

5.  Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study.

Authors:  Lobna Ibrahim; Nancy Diazgranados; Jose Franco-Chaves; Nancy Brutsche; Ioline D Henter; Phillip Kronstein; Ruin Moaddel; Irving Wainer; David A Luckenbaugh; Husseini K Manji; Carlos A Zarate
Journal:  Neuropsychopharmacology       Date:  2012-02-01       Impact factor: 7.853

6.  Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial.

Authors:  Carlos A Zarate; Nancy E Brutsche; Lobna Ibrahim; Jose Franco-Chaves; Nancy Diazgranados; Anibal Cravchik; Jessica Selter; Craig A Marquardt; Victoria Liberty; David A Luckenbaugh
Journal:  Biol Psychiatry       Date:  2012-01-31       Impact factor: 13.382

Review 7.  The neurobiology of the switch process in bipolar disorder: a review.

Authors:  Giacomo Salvadore; Jorge A Quiroz; Rodrigo Machado-Vieira; Ioline D Henter; Husseini K Manji; Carlos A Zarate
Journal:  J Clin Psychiatry       Date:  2010-05-04       Impact factor: 4.384

Review 8.  The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders.

Authors:  Mauricio Tohen; Ellen Frank; Charles L Bowden; Francesc Colom; S Nassir Ghaemi; Lakshmi N Yatham; Gin S Malhi; Joseph R Calabrese; Willem A Nolen; Eduard Vieta; Flávio Kapczinski; Guy M Goodwin; Trisha Suppes; Gary S Sachs; Kn Roy Chengappa; Heinz Grunze; Philip B Mitchell; Shigenobu Kanba; Michael Berk
Journal:  Bipolar Disord       Date:  2009-08       Impact factor: 6.744

Review 9.  The use of antidepressants in bipolar disorder.

Authors:  Virginio Salvi; Andrea Fagiolini; Holly A Swartz; Giuseppe Maina; Ellen Frank
Journal:  J Clin Psychiatry       Date:  2008-08       Impact factor: 4.384

10.  Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD.

Authors:  Joseph F Goldberg; Roy H Perlis; S Nassir Ghaemi; Joseph R Calabrese; Charles L Bowden; Stephen Wisniewski; David J Miklowitz; Gary S Sachs; Michael E Thase
Journal:  Am J Psychiatry       Date:  2007-09       Impact factor: 18.112
View more
  15 in total

1.  Ketamine for depression: evidence, challenges and promise.

Authors:  Carlos A Zarate; Mark J Niciu
Journal:  World Psychiatry       Date:  2015-10       Impact factor: 49.548

2.  In vivo ketamine-induced changes in [¹¹C]ABP688 binding to metabotropic glutamate receptor subtype 5.

Authors:  Christine DeLorenzo; Nicole DellaGioia; Michael Bloch; Gerard Sanacora; Nabeel Nabulsi; Chadi Abdallah; Jie Yang; Ruofeng Wen; J John Mann; John H Krystal; Ramin V Parsey; Richard E Carson; Irina Esterlis
Journal:  Biol Psychiatry       Date:  2014-07-10       Impact factor: 13.382

Review 3.  Ketamine and Beyond: Investigations into the Potential of Glutamatergic Agents to Treat Depression.

Authors:  Marc S Lener; Bashkim Kadriu; Carlos A Zarate
Journal:  Drugs       Date:  2017-03       Impact factor: 9.546

Review 4.  Glutamatergic Modulators in Depression.

Authors:  Ioline D Henter; Rafael Teixeira de Sousa; Carlos A Zarate
Journal:  Harv Rev Psychiatry       Date:  2018 Nov/Dec       Impact factor: 3.732

5.  Pharmacologic approaches to treatment resistant depression: Evidences and personal experience.

Authors:  Antonio Tundo; Rocco de Filippis; Luca Proietti
Journal:  World J Psychiatry       Date:  2015-09-22

Review 6.  Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression.

Authors:  Ioline D Henter; Rafael T de Sousa; Philip W Gold; Andre R Brunoni; Carlos A Zarate; Rodrigo Machado-Vieira
Journal:  Expert Rev Clin Pharmacol       Date:  2017-01-16       Impact factor: 5.045

Review 7.  Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review.

Authors:  Nicolas D Iadarola; Mark J Niciu; Erica M Richards; Jennifer L Vande Voort; Elizabeth D Ballard; Nancy B Lundin; Allison C Nugent; Rodrigo Machado-Vieira; Carlos A Zarate
Journal:  Ther Adv Chronic Dis       Date:  2015-05       Impact factor: 5.091

Review 8.  The influence of ketamine on drug discovery in depression.

Authors:  Christoph Kraus; Daniel Wasserman; Ioline D Henter; Elia Acevedo-Diaz; Bashkim Kadriu; Carlos A Zarate
Journal:  Drug Discov Today       Date:  2019-08-02       Impact factor: 7.851

9.  Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression.

Authors:  Annie J Xu; Mark J Niciu; Nancy B Lundin; David A Luckenbaugh; Dawn F Ionescu; Erica M Richards; Jennifer L Vande Voort; Elizabeth D Ballard; Nancy E Brutsche; Rodrigo Machado-Vieira; Carlos A Zarate
Journal:  Neural Plast       Date:  2015-06-07       Impact factor: 3.599

10.  Ketamine-induced affective switch in a patient with treatment-resistant depression.

Authors:  Girish Banwari; Prutha Desai; Prahlad Patidar
Journal:  Indian J Pharmacol       Date:  2015 Jul-Aug       Impact factor: 1.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.